本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Carisma Therapeutics

0.3685
-0.0715-16.25%
成交量:1,436.10万
成交额:572.16万
市值:1,539.89万
市盈率:-0.31
高:0.4274
开:0.4012
低:0.3528
收:0.4400
52周最高:1.27
52周最低:0.1417
股本:4,178.81万
流通股本:3,125.58万
量比:0.25
换手率:45.95%
股息:- -
股息率:- -
每股收益(TTM):-1.1834
每股收益(LYR):-1.4588
净资产收益率:-362.79%
总资产收益率:-85.68%
市净率:-0.33
市盈率(LYR):-0.25

数据加载中...

2025/08/29

重要事件披露

Form 8-K - Current report
2025/08/29

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/08/08

重要事件披露

Form 8-K - Current report
2025/08/08

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/08/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/07/15

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/07/15

重要事件披露

Form 8-K - Current report
2025/06/25

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/06/23

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/06/23

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/06/23

重要事件披露

Form 8-K - Current report
2025/06/23

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/06/12

重要事件披露

Form 8-K - Current report
2025/05/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/04/30

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2025/04/16

重要事件披露

Form 8-K - Current report
2025/03/31

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/31

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/01/13

重要事件披露

Form 8-K - Current report
2025/01/10

重要事件披露

Form 8-K - Current report